ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Empowering Freenome: Large-Scale Data Quality And Compliance

  Delve into five ways this biotech company was able to successfully deliver data quality and compliance for large-scale trials while developing next-generation blood tests for early cancer detection.

• Digital Advancements In Clinical Development - What's Next?

  Review this year's predictions for improving digital biomarkers and data analytics, bettering endpoint sensitivity and specificity, and reducing timelines and costs of clinical development.

• Myth Or Fact: The Future Of Electronic Data Capture

  Explore how EDC platforms are empowering researchers to conduct efficient trials regardless of data volume, source diversity, or patient demographics.

• How To Streamline The Complexity Of Clinical Trials

  Streamlining intricate end-to-end processes ensures that data moves with speed and security, converting the current landscape of logistical bottlenecks into a transparent, high-efficiency engine.

• Clinical Trials Are The Global Biopharma Industry's Biggest Headache

  Explore how technology-driven, patient-centered innovation is transforming clinical trials to reduce risk, improve efficiency, and deliver smarter development outcomes.

• IRT: A New Approach To Meeting The Needs Of Early Phase Trials

  As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.

• Outsourcing Data Management: Challenges And Benefits

  Life sciences companies are grappling with a deluge of data. Yet strategic data management outsourcing offers potential benefits amidst regulatory and interoperability hurdles.

• Maximize The Value Of Wearable Data

  Explore this near real-time adherence monitoring solution for clinical trial sponsors that compares wearable device data collected from a participant's scheduled activities and visit dates.

• Letter From The CEO: A New Era Of Drug Development Is Here

  This letter from Medable CEO Michelle Longmire lays out why we created Studio, what it enables sponsors and CROs to do, and how it will help everyone bring more effective therapies to patients faster.

• Deconstructing Central Rating In Clinical Trials

  Analyze several commonly held misconceptions about Central Rating and its ability to ensure data validity and study success in this